Abstract
It is recommended that routine bone scans not be adopted for follow-up of patients with stage I-II breast cancer. Bone scintigraphy should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.
MeSH terms
-
Bone Neoplasms / diagnostic imaging*
-
Bone Neoplasms / secondary*
-
Breast Neoplasms / diagnostic imaging
-
Breast Neoplasms / pathology*
-
Cost-Benefit Analysis
-
Female
-
Humans
-
Patient Selection
-
Quality of Life
-
Radionuclide Imaging / economics
-
Survival Rate